Jade Biosciences (JBIO) Non-Current Assets (2020 - 2026)

Jade Biosciences (JBIO) has 7 years of Non-Current Assets data on file, last reported at $916000.0 in Q1 2026.

• Quarterly Non-Current Assets rose 472.5% year-over-year to $916000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $4.0 million (down 13.89% YoY) and the FY2025 annual result came in at $965000.0, down 69.32% from the prior year.
• Non-Current Assets fell to $916000.0 in Q1 2026, from $965000.0 in the prior quarter.
• In the past five years, Non-Current Assets ranged from a high of $3.8 million in Q1 2023 to a low of $160000.0 in Q1 2025.
• A 5-year average of $2.1 million and a median of $2.2 million in 2022 frame the typical range for Non-Current Assets.
• Annual changes were most pronounced in 2025 — Non-Current Assets plunged 95.53% — and 2026, when it jumped 472.5%.
• Tracing JBIO's Non-Current Assets over 5 years: stood at $3.8 million in 2022, then retreated by 16.27% to $3.2 million in 2023, then declined by 1.29% to $3.1 million in 2024, then slumped by 69.32% to $965000.0 in 2025, then retreated by 5.08% to $916000.0 in 2026.
• The last three Non-Current Assets figures came in at $916000.0 (Q1 2026), $965000.0 (Q4 2025), and $1.1 million (Q3 2025), per Business Quant data.